Assessment of Different Clinical Techniques to Treat Patients With Chronic Low Back Pain
Unknown statusNot applicableNCT06453291
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
This clinical trial aims to assess the effectiveness of different clinical techniques in treating patients with chronic low back pain (CLBP). Two test groups will be included: one receiving conventional therapy (NSAIDs and other physical therapy techniques) and the other receiving a combination of neuromodulation and platelet-rich plasma (PRP) therapy. Chronic pain, persisting for more than three months, inhibits natural pathways like GABA and promotes excitatory pathways, leading to increased inflammation. The study hypothesizes that neuromodulation via the dorsal root ganglion (DRG) and PRP therapy will provide superior pain relief and functional improvement compared to conventional therapy.
Study details
- Official title
- Innovative Approaches in Managing Chronic Low Back Pain: A Comparative Assessment of Clinical Techniques
- Conditions
- Interventions
- Drug: NSAIDs (Nonsteroidal Anti-Inflammatory Drugs):
- Procedure: Standard Physical Therapy
- Procedure: Neuromodulation via Dorsal Root Ganglion (DRG):
- Procedure: Platelet-Rich-Plasma Therapy
- Sponsor
- Iffat Anwar Medical Complex
- Start date
- 2024-07-10
- Primary completion
- 2025-04
- Sex
- All
- Age range
- from 40 Years to 60 Years
- Healthy volunteers
- true
- Results posted
- No results posted in this snapshot
- Countries
- Pakistan
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Adults aged 40-60 years. * Diagnosed with chronic low back pain persisting for more than three months. * Willingness to participate and comply with study procedures. * Ability to provide informed consent. Exclusion Criteria: * Comorbidities. * Contagious and Non-Contagious Infections * Known hypersensitivity to study interventions. * Presence of severe psychiatric disorders. * Pregnancy or breastfeeding. * Participation in another clinical trial within the last 30 days.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT06453291